Plain-English translation of NCT07192705 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Researchers want to understand how non-tuberculous mycobacteria pulmonary disease (NTM-PD)—a chronic lung infection caused by bacteria found in soil and water—affects people's health and daily lives. This study will compare people who have been diagnosed with NTM-PD to people who have damaged airways (bronchiectasis) but do not have this specific infection. By looking at symptoms, test results, and what helps patients feel better, the team hopes to improve care for people living with NTM-PD.
NTM-PD is a serious, long-lasting lung condition that worsens over time and can significantly impact people's quality of life. However, doctors don't yet fully understand which symptoms matter most to patients or what non-medication support might help most. This research aims to fill that gap so treatment can be tailored better to what patients actually need.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will share your medical history, symptoms, and test results with the research team—likely through discussions and review of your medical records. You may also complete surveys about which symptoms bother you most and what kinds of non-medication support would help you. The study is observational, meaning researchers are watching and learning from your experience rather than testing a new treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United Kingdom